Abstract
In type 1 diabetes (T1D), a break in central and peripheral tolerance results in antigen-specific T cells destroying insulin-producing, pancreatic beta cells. Herein, we discuss the critical sub-population of dendritic cells responsible for mediating both the cross-presentation of islet antigen to CD8+ T cells and the direct presentation of beta cell antigen to CD4+ T cells. These cells, termed merocytic dendritic cells (mcDC), are more numerous in non-obese diabetic (NOD), and antigen-loaded mcDC rescue CD8+ T cells from peripheral anergy and deletion, and stimulate islet-reactive CD4+ T cells. When purified from the pancreatic lymph nodes of overtly diabetic NOD mice, mcDC can break peripheral T cell tolerance to beta cell antigens in vivo and induce rapid onset T cell-mediated T1D in young NOD mouse. Thus, the mcDC subset appears to represent the long-sought critical antigen-presenting cell responsible for breaking peripheral tolerance to beta cell antigen in vivo.
Similar content being viewed by others
Abbreviations
- T1D:
-
Type 1 diabetes
- Ag:
-
Antigen(s)
- TCR:
-
T cell receptor
- APC:
-
Antigen-presenting cell
- DC:
-
Dendritic cell(s)
- FLT3:
-
Fms-like tyrosine kinase 3
- FLT3L:
-
FLT3 ligand
- mcDC:
-
Merocytic dendritic cells
- IKDC:
-
Natural killer dendritic cells
- Th1/Tc1:
-
T helper cell type 1/T cytotoxic cell type 1
- pDC:
-
Plasmacytoid dendritic cells
- cDC:
-
Conventional dendritic cells
- PLN:
-
Pancreatic lymph nodes
- CLP:
-
Common lymphoid precursors
- CMP:
-
Common myeloid precursors
- NOD:
-
Non-obese diabetic
References
Atkinson MA (2005) ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can’t we prevent or reverse this disease? Diabetes 54:1253–1263
Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033
Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith G, Bloch C, Rewers M, Dabelea D (2007) Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care 30:503–509
Cordell HJ, Todd JA (1995) Multifactorial inheritance in type 1 diabetes. Trends Genet 11:499–504
Cordell HJ, Todd JA, Lathrop GM (1998) Mapping multiple linked quantitative trait loci in non-obese diabetic mice using a stepwise regression strategy. Genet Res 71:51–64
Ridgway WM (2003) The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses. Rev Endocr Metab Disord 4:263–269
Wicker LS, Miller BJ, Mullen Y (1986) Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855–860
Bedossa P, Bendelac A, Bach JF, Carnaud C (1989) Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 19:1947–1951
Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 166:823–832
Katz J, Benoist C, Mathis D (1993) Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 23:3358–3360
Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB (1994) Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500–504
Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC (1994) Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43:505–509
Wändell PE (2005) Quality of life of patients with diabetes mellitus: an overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 23:68–74
Anonoymous (2005) Guidelines. National Institute of Clinical Excellence. Diabet Med 22(Suppl 1):5–6
Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M (1992) Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 22:2387–2393
Christianson SW, Shultz LD, Leiter EH (1993) Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42:44–55
Hayward AR, Shriber M, Cooke A, Waldmann H (1993) Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. J Autoimmun 6:301–310
Wang B, Gonzalez A, Benoist C, Mathis D (1996) The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 26:1762–1769
Serreze DV, Gallichan WS, Snider DP, Croitoru K, Rosenthal KL, Leiter EH, Christianson GJ, Dudley ME, Roopenian DC (1996) MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes 45:902–908
Katz JD, Wang B, Haskins K, Benoist C, Mathis D (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089–1100
Tsai S, Shameli A, Santamaria P (2008) CD8+ T cells in type 1 diabetes. Adv Immunol 100:79–124
DiLorenzo TP, Serreze DV (2005) The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 204:250–263
Dilts SM, Solvason N, Lafferty KJ (1999) The role of CD4 and CD8 T cells in the development of autoimmune diabetes. J Autoimmun 13:285–290
Wong FS, Janeway CAJ (1997) The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. Res Immunol 148:327–332
Haskins K, Wegmann D (1996) Diabetogenic T-cell clones. Diabetes 45:1299–1305
André I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D (1996) Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA 93:2260–2263
Kurrer MO, Pakala SV, Hanson HL, Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213–218
Pakala SV, Chivetta M, Kelly CB, Katz JD (1999) In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189:1053–1062
Mathis D, Vence L, Benoist C (2001) Beta-cell death during progression to diabetes. Nature 414:792–798
O’Brien BA, Harmon BV, Cameron DP, Allan DJ (1997) Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46:750–757
O’Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT (2002) Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51:2481–2488
O’Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, Bush JA, Li G, Finegood DT, Dutz JP (2006) A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26:104–115
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23:227–239
Mathis D, Benoist C (2007) A decade of AIRE. Nat Rev Immunol 7:645–650
Mathis D, Benoist C (2009) Aire. Annu Rev Immunol 27:287–312
Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K (1988) T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444–1448
Bradley BJ, Wang YY, Lafferty KJ, Haskins K (1990) In vivo activity of an islet-reactive T-cell clone. J Autoimmun 3:449–456
Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Piganelli JD, Barbour G, Bradley B, Crawford F, Marrack P, Mahata SK, Kappler JW, Haskins K (2010) Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 11:225–231
Kanagawa O, Shimizu J, Vaupel BA (2000) Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. J Immunol 164:5466–5473
Cain JA, Smith JA, Ondr JK, Wang B, Katz JD (2006) NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol 176:1645–1654
Lühder F, Katz J, Benoist C, Mathis D (1998) Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J Exp Med 187:379–387
Höglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331–339
Santamaria P, Utsugi T, Park BJ, Averill N, Kawazu S, Yoon JW (1995) Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. J Immunol 154:2494–2503
Santamaria P (2010) The long and winding road to understanding and conquering type 1 diabetes. Immunity 32:437–445
DiLorenzo TP, Graser RT, Ono T, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV (1998) Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci USA 95:12538–12543
Haskins K (2004) T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones. J Autoimmun 22:107–109
Nir T, Melton DA, Dor Y (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117:2553–2561
Brennand K, Huangfu D, Melton D (2007) All beta cells contribute equally to islet growth and maintenance. PLoS Biol 5:e163
Gu G, Dubauskaite J, Melton DA (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129:2447–2457
Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249–256
Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736–1741
Petrik J, Arany E, McDonald TJ, Hill DJ (1998) Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 139:2994–3004
Turley S, Poirot L, Hattori M, Benoist C, Mathis D (2003) Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 198:1527–1537
Belz GT, Carbone FR, Heath WR (2002) Cross-presentation of antigens by dendritic cells. Crit Rev Immunol 22:439–448
Belz GT, Shortman K, Bevan MJ, Heath WR (2005) CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol 175:196–200
Roos A, Xu W, Castellano G, Nauta AJ, Garred P, Daha MR, van Kooten C (2004) Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34:921–929
Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K (2006) Efficient T cell activation via a Toll-interleukin 1 receptor-independent pathway. Immunity 24:787–799
Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunol Rev 234:45–54
Schmid MA, Kingston D, Boddupalli S, Manz MG (2010) Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 234:32–44
Steinman RM, Idoyaga J (2010) Features of the dendritic cell lineage. Immunol Rev 234:5–17
Bedoui S, Prato S, Mintern J, Gebhardt T, Zhan Y, Lew AM, Heath WR, Villadangos JA, Segura E (2009) Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J Immunol 182:4200–4207
Qiu C, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M (2009) Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 182:4127–4136
Bonmort M, Dalod M, Mignot G, Ullrich E, Chaput N, Zitvogel L (2008) Killer dendritic cells: IKDC and the others. Curr Opin Immunol 20:558–565
Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–258
Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153–162
Savina A, Amigorena S (2007) Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219:143–156
Williams CA, Harry RA, McLeod JD (2008) Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. Immunology 124:89–101
Peng YF, Elkon KB (2007) Peripheral CD8 T-cell responses to apoptotic cell proteins and peptides. Crit Rev Immunol 27:357–365
Ferguson TA, Kazama H (2005) Signals from dying cells: tolerance induction by the dendritic cell. Immunol Res 32:99–108
Saas P, Bonnefoy F, Kury-Paulin S, Kleinclauss F, Perruche S (2007) Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation 84:S31–S34
Shortman K, Heath WR (2010) The CD8+ dendritic cell subset. Immunol Rev 234:18–31
Schulz O, Reis e Sousa C (2002) Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107:183–189
Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, Takahara K, Steinman RM, Inaba K (2002) The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195:1289–1302
Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre C, Ventre E, Vu Manh T, Baranek T, Storset AK, Marvel J, Boudinot P, Hosmalin A, Schwartz-Cornil I, Dalod M (2010) The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 207:1283–1292
Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJE, Hart DNJ, Radford KJ (2010) Human CD141+(BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207:1247–1260
Bachem A, Güttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, Salama A, Movassaghi K, Opitz C, Mages HW, Henn V, Kloetzel P, Gurka S, Kroczek RA (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c+ CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207:1273–1281
Hoeffel G, Ripoche A, Matheoud D, Nascimbeni M, Escriou N, Lebon P, Heshmati F, Guillet J, Gannagé M, Caillat-Zucman S, Casartelli N, Schwartz O, De la Salle H, Hanau D, Hosmalin A, Marañón C (2007) Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27:481–492
Colonna M, Cella M (2007) Crosspresentation: plasmacytoid dendritic cells are in the business. Immunity 27:419–421
Irla M, Küpfer N, Suter T, Lissilaa R, Benkhoucha M, Skupsky J, Lalive PH, Fontana A, Reith W, Hugues S (2010) MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J Exp Med 207:1891–1905
Hennies CM, Reboulet RA, Garcia Z, Nierkens S, Wolkers MC, Janssen EM (2011) Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo. Clin Exp Immunol 163:381–391
Reboulet RA, Hennies CM, Garcia Z, Nierkens S, Janssen EM (2010) Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice. J Immunol 185:3337–3347
Steptoe RJ, Ritchie JM, Harrison LC (2003) Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest 111:1357–1363
Spierings DCJ, Lemmens EE, Grewal K, Schoenberger SP, Green DR (2006) Duration of CTL activation regulates IL-2 production required for autonomous clonal expansion. Eur J Immunol 36:1707–1717
Kaech SM, Ahmed R (2001) Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat Immunol 2:415–422
Belz GT, Kallies A (2010) Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination. Curr Opin Immunol 22:279–285
Marrack P, Kappler J, Mitchell T (1999) Type I interferons keep activated T cells alive. J Exp Med 189:521–530
Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, Rossmann C, Kalinke U, Tough DF (2006) Direct stimulation of T cells by type I IFN enhances the CD8 + T cell response during cross-priming. J Immunol 176:4682–4689
Huber JP, David Farrar J (2011) Regulation of effector and memory T-cell functions by type I interferon. Immunology 132:466–474
Sun JC, Bevan MJ (2003) Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339–342
Shedlock DJ, Shen H (2003) Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337–339
Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852–856
Hamilton-Williams EE, Lang A, Benke D, Davey GM, Wiesmüller K, Kurts C (2005) Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol 174:1159–1163
Krawczyk CM, Shen H, Pearce EJ (2007) Memory CD4 T cells enhance primary CD8 T-cell responses. Infect Immun 75:3556–3560
Williams MA, Holmes BJ, Sun JC, Bevan MJ (2006) Developing and maintaining protective CD8+ memory T cells. Immunol Rev 211:146–153
Rosmalen JG, Leenen PJ, Katz JD, Voerman JS, Drexhage HA (1997) Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes. Adv Exp Med Biol 417:291–294
Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43:667–675
de Jong MAWP, Geijtenbeek TBH (2010) Langerhans cells in innate defense against pathogens. Trends Immunol 31:452–459
Nikolic T, Bouma G, Drexhage HA, Leenen PJM (2005) Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro. J Leukoc Biol 78:70–79
Nikolic T, Geutskens SB, van Rooijen N, Drexhage HA, Leenen PJ M (2005) Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 85:487–501
Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD (2007) The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol 179:5041–5053
Katz JD, Ondr JK, Opoka RJ, Garcia Z, Janssen EM (2010) Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes. J Immunol 185:1999–2003
Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, McDevitt HO (2008) Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 105:12439–12444
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katz, J.D., Janssen, E.M. Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells. Cell. Mol. Life Sci. 68, 2873–2883 (2011). https://doi.org/10.1007/s00018-011-0730-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-011-0730-6